Abstract
The purpose of this study was to assess whether intraocular silicone oil causes systemic antipolymer antibody (APA) production at a greater incidence than in individuals without exposure to intraocular silicone oil. The cross-sectional, randomized sample was obtained from 3 university-based hospitals (21 patients with complex vitreoretinal disorders) and treated with intraocular silicone oil. Compared with the general population, patients treated with silicone oil did not have an increased incidence of APA production.
Similar content being viewed by others
References
Tenenbaum SA, Rice JC, Espinoza LR, et al Use of antipolmer antibody assay in recipients of silicone breast implants. Lancet. 1997;349:449–454.
The Silicone Study Group. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Arch Ophthalmol. 1992; 110:770–779.
Tenenbaum SA, Cuellar ML, Garry RF, Espinoza LR. Production of antibodies to partially cross-linked polymers in silicone breast recipients. Arthritis Rheum. 1993;S118:A123.
Javid CG, Maxwell DP Jr, Diamond JE, Garry RF. Poster presented at: Annual Meeting of the Vitreous Society; September 18–21, 1997; New Orleans, La
Author information
Authors and Affiliations
Additional information
This work was presented as a scientific, poster, 1997 Vitreous Society Annual Meeting, New Orleans, La., September 18–21 1997.
Rights and permissions
About this article
Cite this article
Javid, C.G., Maxwell, D.P., Diamond, J.E. et al. Serum antibody testing in patients treated with intraocular silicone oil. Ann Ophthalmol 33, 53–55 (2001). https://doi.org/10.1007/s12009-001-0056-3
Issue Date:
DOI: https://doi.org/10.1007/s12009-001-0056-3